QSAM Biosciences, Inc. (QSAM)
OTCMKTS: QSAM · Delayed Price · USD
16,600
0.00 (0.00%)
May 2, 2024, 3:59 PM EDT - Market closed
QSAM Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.39 | 0.23 | 1.5 | 0.01 | 0 | 0.16 | 0.3 | 0 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 1.39 | 0.23 | 1.5 | 0.01 | 0 | 0.16 | 0.3 | 0 | 0 | 0 | Upgrade
|
| Cash Growth | 515.42% | -84.98% | 17961.97% | 1637.24% | -99.70% | -46.42% | 8869.16% | 229.05% | 156.20% | -80.66% | Upgrade
|
| Receivables | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.07 | 0.14 | 0.17 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.02 | 0.03 | Upgrade
|
| Total Current Assets | 1.71 | 0.36 | 1.67 | 0.02 | 0.01 | 0.16 | 0.3 | 0.01 | 0.03 | 0.03 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.02 | 0 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.2 | 0 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0.03 | -0 | 0 | -0 | -0 | -0 | 0 | 0 | Upgrade
|
| Total Long-Term Assets | 0 | 0 | 0.03 | 0.02 | 0 | 0 | 0 | 0.08 | 0.21 | 0 | Upgrade
|
| Total Assets | 1.71 | 0.36 | 1.67 | 0.02 | 0.01 | 0.16 | 0.31 | 0.09 | 0.24 | 0.03 | Upgrade
|
| Accounts Payable | 0.57 | 0.75 | 0.57 | 0.31 | 0.24 | 0.17 | 0.11 | 0.8 | 0.54 | 0.09 | Upgrade
|
| Deferred Revenue | -1,025,398.54 | 0 | 0 | 0 | 0 | 0.13 | 0.01 | 0.31 | 0.26 | 0 | Upgrade
|
| Current Debt | 0.01 | 0.45 | 0.57 | 3.83 | 3.39 | 0.17 | 0.17 | 0.46 | 0.01 | 0.22 | Upgrade
|
| Other Current Liabilities | 1,025,399 | 0.38 | 0.25 | 0.05 | 0.17 | 0 | 0 | 0.21 | 1.65 | 0.07 | Upgrade
|
| Total Current Liabilities | 1.03 | 1.58 | 1.39 | 4.19 | 3.8 | 0.46 | 0.29 | 1.78 | 2.47 | 0.38 | Upgrade
|
| Long-Term Debt | 0 | 0 | 0.53 | 0.11 | 0.03 | 2.96 | 3.27 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 1.57 | 0.32 | 0.3 | Upgrade
|
| Total Long-Term Liabilities | 1 | 1.2 | 0.53 | 0.11 | 0.03 | 2.96 | 3.27 | 1.57 | 0.32 | 0.3 | Upgrade
|
| Total Liabilities | 1.03 | 1.58 | 1.39 | 4.3 | 3.83 | 3.42 | 3.56 | 1.78 | 2.78 | 0.38 | Upgrade
|
| Total Debt | 0.01 | 0.45 | 0.57 | 3.94 | 3.43 | 3.13 | 3.44 | 0.46 | 0.01 | 0.22 | Upgrade
|
| Debt Growth | -98.34% | -21.52% | -85.42% | 15.06% | 9.65% | -9.02% | 651.39% | 4600.32% | -95.56% | 630.85% | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Retained Earnings | -40.16 | -35.18 | -29.28 | -15.91 | -11.05 | -10.37 | -9.97 | -6.86 | -5.37 | -5.66 | Upgrade
|
| Comprehensive Income | -1.35 | -0.19 | -0.9 | -0.15 | 0 | 0 | -0 | -0 | -0 | -0 | Upgrade
|
| Shareholders' Equity | 0.67 | -1.22 | 0.28 | -4.28 | -3.82 | -3.26 | -3.25 | -1.69 | -2.55 | -0.35 | Upgrade
|
| Total Liabilities and Equity | 1.71 | 0.36 | 1.67 | 0.02 | 0.01 | 0.16 | 0.31 | 0.09 | 0.24 | 0.03 | Upgrade
|
| Net Cash / Debt | 1.38 | -0.23 | 0.92 | -3.93 | -3.43 | -2.96 | -3.14 | -0.45 | -0.01 | -0.22 | Upgrade
|
| Net Cash Per Share | 0.45 | -0.13 | 1.17 | -28.49 | -65.89 | -59.46 | -67.21 | -15.96 | -0.52 | -140.75 | Upgrade
|
| Working Capital | 0.67 | -1.22 | 0.28 | -4.17 | -3.79 | -0.3 | 0.02 | -1.77 | -2.44 | -0.35 | Upgrade
|
| Book Value Per Share | 0.22 | -0.69 | 0.35 | -30.98 | -73.56 | -65.34 | -69.68 | -59.45 | -152.62 | -224.22 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.